This country profile provides an overview of Gambia’s progress in reaching those in need of mass NTD treatment based on 2016 data.

NTD mass treatment coverage index: 8/100
Overall rank: 31st

Treatment coverage

Lymphatic filariasis
N/A
Onchocerciasis
N/A
Schistosomiasis
0%
STH
47%
Trachoma
100%
38,000 people received treatment in Gambia in 2016 139,000 people in need did not receive treatment in Gambia in 2016

Gambia recommendations

These recommendations were given to heads of state at the African Union summit in January 2017 as part of the ALMA Scorecard for Accountability and Action.

  • Given the good coverage achieved in soil-transmitted helminths (STH) preventive chemotherapy (PC), implement PC for schistosomiasis alongside STH, at least for school-aged children.
  • Support the development of the elimination dossier to achieve WHO recognition of achievements in trachoma elimination.
  • Reconfirm trachoma prevalence, whilst continuing to deliver surgery as part of the SAFE strategy.
  • Increase budget allocation for neglected tropical diseases at the national level.
  • Provide timely date to the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) to enable monitoring and planning.

Lymphatic filariasis

Gambia does not require mass treatment for lymphatic filariasis.

Onchocerciasis

Gambia does not require mass treatment for onchocerciasis.

Schistosomiasis

Treatment coverage remained the same at 0% in 2015 and 2016.

School-aged children needing treatment
108,000
School-aged children receiving treatment
0 reported

Soil-transmitted helminths

⬆️ Treatment coverage increased from 0% in 2015 to 47% in 2016.

Pre-sch and school-aged children needing treatment
82,000
Pre-school and school-aged children receiving treatment
38,000

Trachoma

Treatment coverage was 100% in 2016.

People needing treatment
0 reported
People receiving treatment
0 reported